Original Article

Disability and Health-Related Quality of Life after Breast Cancer Surgery: Relation to Impairments

Authors: Taciser Kaya, AP, Altinay Göksel Karatepe, MD, Rezzan Günaydin, AP, Halit Yetiş, MD, Adam Uslu, AP

Abstract

Background: The aim of this study was to determine the prevalence of impairments relevant to upper extremity following breast cancer surgery and its impact on disability and health-related quality of life.


Methods: Sixty-seven female patients being treated with modified radical mastectomy or breast conserving surgery were included. They were evaluated for impairments (arm edema, loss of handgrip strength, limited shoulder joint range of motion, and pain), physical disability using the disabilities of the arm, shoulder, and hand (DASH) questionnaire, and for health related quality of life by means of the functional assessment of cancer therapy-breast+4 (FACT-B+4).


Results: The most common impairment observed was arm pain on motion; the cause of 20% variance in disability score (r2 = 0.203, P = 0.000). Arm pain on motion, anterior chest wall pain, loss of grip strength, and shoulder flexion were significant factors in different domains of quality of life according to the FACT-B+4 questionnaire.


Conclusion: Pain relief should be the priority of treatment along with the prevention of joint movement restriction to ensure a sufficient quality of life for surgically treated breast cancer patients.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1.Kwan W, Jackson J, Weir LM, et al. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol 2002;20:4242–4248.
 
2.Beaulac SM, McNair LA, Scott TE, et al. Lymphedema and quality of life in survivors of early-stage breast cancer. Arch Surg 2002;137:1253–1257.
 
3.Tsai RJ, Dennis LK, Lynch CF, et al. The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol 2009;16:1959–1972.
 
4.Erickson VS, Pearson ML, Ganz PA, et al. Arm edema in breast cancer patients. J Natl Cancer Inst2001;93:96–111.
 
5.Dawes DJ, Meterissian S, Goldberg M, et al. Impact of lymphoedema on arm functıon and health-related quality of life in women following breast cancer surgery. J Rehabil Med 2008;40:651–658.
 
6.Coster S, Poole K, Fallowfield LJ. The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively. Breast Cancer Res Treat 2001;68:273–282.
 
7.Rietman JS, Dijkstra PD, Debreczeni R, et al. Impairments, disabilities and health related quality of life after treatment for breast cancer: a follow-up study 2.7 years after surgery. Disabil Rehabil2004;26:78–84.
 
8.Dubernard G, Sideris L, Delaloge S, et al. Quality of life after sentinel lymph node biopsy in early breast cancer. Eur J Surg Oncol 2004;30:728–734.
 
9.Madden JL. Modified radical mastectomy. Surg Gynecol Obstet 1965;121:1221–1230.
 
10.McKenzie DC, Kalda AL. Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: a pilot study. J Clin Oncol 2003;21:463–466.
 
11.Jansen RF, Geel van AN, de Groot HG, et al. Immediate versus delayed shoulder exercises after axillary lymph node dissection. Am J Surg 1990;160:481–484.
 
12.Hladiuk M, Huchcroft S, Temple W, et al. Arm function after axillary dissection for breast cancer: a pilot study to provide parameter estimates. J Surg Oncol 1992;50:47–52.
 
13.Beaton DE, Katz JN, Fossel AH, et al. Measuring the whole or the parts? Validity, reliability, and responsiveness of the disabilities of the arm, shoulder and hand outcome measure in different regions of the upper extremity. J Hand Ther 2001;14:128–146.
 
14.Jester A, Harth A, Wind G, et al. Disabilities of the arm, shoulder and hand (DASH) questionnaire: determining functional activity profiles in patients with upper extremity disorders. J Hand Surg Br2005;30:23–28.
 
15.Brady MJ, Cella DF, Mo F, et al. Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument. J Clin Oncol 1997;15:974–986.
 
16.Caffo O, Amichetti M, Ferro A, et al. Pain and quality of life after surgery for breast cancer. Breast Cancer Res Treat 2003;80:39–48.
 
17.Armer J, Fu MR. Age differences in post-breast cancer lymphedema signs and symptoms. Cancer Nurs 2005;28:200–207.
 
18.Hack TF, Cohen L, Katz J, et al. Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 1999;17:143–149.
 
19.Segerström K, Bjerle P, Nyström A. Importance of time in assessing arm and hand function after treatment of breast cancer. Scand J Plast Reconstr Surg Hand Surg 1991;25:241–244.
 
20.Nagel PH, Bruggink ED, Wobbes T, et al. Arm morbidity after complete axillary lymph node dissection for breast cancer. Acta Chir Belg 2003;103:212–216.
 
21.Ernst MF, Voogd AC, Balder W, et al. Early and late morbidity associated with axillary levels I-III dissection in breast cancer. J Surg Oncol 2002;79:151–155.
 
22.Thomas-MacLean RL, Hack T, Kwan W, et al. Arm morbidity and disability after breast cancer: new directions for care. Oncol Nurs Forum 2008;35:65–71.
 
23.Clark B, Sitzia J, Harlow W. Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. Q J Med 2005;98:343–348.
 
24.Albert US, Koller M, Kopp I, et al. Early self-reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: results from a population-based cohort study. Breast Cancer Res Treat 2006;100:285–292.
 
25.Rietman JS, Dijkstra PU, Hoekstra HJ, et al. Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol 2003;29:229–238.
 
26.Hayes SC, Janda M, Cornish B, et al. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol 2008;26:3536–3542.